首页 正文

Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis

{{output}}
Our objective is to report a case of bilateral nodular scleritis in a 34-year-old patient, resistant to steroids and traditional disease modifying anti-rheumatic drugs, who was successfully treated with subcutaneous injections of 40 mg adalimumab. Adalimumab r... ...